First Gene Therapy — ‘a True Living Drug’ — on the Cusp of FDA Approval

Experimental immunotherapy CAR T-cell treatment developed by researchers in the Perelman School of Medicine is highlighted for its potential FDA approval.

・ From The Washington Post